Patient Oriented Therapy for STE-MI Seçkin Pehlivanoğlu, MD Başkent University, İstanbul Hospital.
The Evolving Science and Controversial Landscape of Antiplatelet Therapy in the Catheterization Laboratory Mechanisms Mortality Therapeutics PROGRAM CO-CHAIRMAN.
Metformin & myocardial infarct size Metformin in Acute Myocardial Infarction in Patients without Diabetes Glycometabolic Interventions in Patients presenting.
Approach to The Low Risk Chest Pain Patient John P Erwin, III, MD, FACC, FAHA Associate Professor of Medicine Scott and White Heart and Vascular Institute.
Jay H. Traverse, MD Principal Investigator, TIME Study Minneapolis Heart Institute at Abbott Northwestern Hospital University of Minnesota Medical School.
Www.europcronline.com/ Stem Cell Therapy & CV Innovations Madrid, April 23 - 24, 2009 Next Steps in Heart Replacement My Clinical View William Wijns Cardiovascular.
Critical Decisions in the Emergency Department University of Pennsylvania: Brendan G. Carr, MD MS Sage Myers, MD MS Scott Lorch, MD MS Patrick Reilly,
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI 261 EVREV 2: Daniel Pichel COI # 513 Taskforce: ACS ACS 335: Pre-hospital ADP- Receptor.
6/29/2015 Individual Task Variability: Linking Process Improvement to Patient and Hospital Outcomes Susan Meyer Goldstein & Rachna Shah Cincinnati Innovations.
1 Acute Coronary Syndromes At the end of this self-study the participant will: Describe the pathophysiology of Acute Coronary Syndromes List signs and.
NYC REMSCO Protocols Jan. 2008 updates Dr. Victor Politi.
Improving STEMI Care: Overcoming Hospital Barriers Eva Kline-Rogers, MS,RN,NP University of Michigan, Ann Arbor, MI Friday, June 3, 3011 No Conflict of.